ABSTRACT

To assess the validity of RESPINOS, a remote monitoring device, to measure the vital signs of patients with mild – moderate COVID-19.

A cross sectional study was conducted in Dr. Soetomo Hospital, Surabaya, Indonesia. All patients with mild – moderate COVID-19 were enrolled to our study, and patients with unable to cooperate in operating the tool were excluded. The implementation of RESPINOS was considered the predictor covariate, and the vital signs were considered the outcome, compared to the measurement of standard device. A t test and kappa agreement were used to assess the similarity between the measurement of RESPINOS and the standard device.

A total of 180 participants was employed to our study. Of them, we found that the measurements of respiratory rate, heart rate, and oxygen saturation had similarity between RESPINOS and the standard device (p > 0.05). Moreover, our analysis in kappa agreement also found that the coefficient of kappa agreement was higher in respiratory rate, heart rate, and oxygen saturation, suggesting that the measurement either by using RESPINOS or standard device provided similar findings.

RESPINOS offers the benefits for a remote monitoring in patients with mild – moderate COVID-19.